ETHICS STATEMENT
This trial was conducted under the approval of central IRB, where the Adult NCI IRB was the IRB of Record for this NCI trial (9775), prior to commencing this study. Additionally the IRB approval was renewed on a yearly basis. All patients on this protocol consented prior to commencing any research activities and while on study. All local sites had this study reviewed and acknowledged by the local IRB, where the Adult NCI IRB was the IRB of record. The lead institution (Mayo Clinic) had its local IRB review and approve this study (IRB‐008314).